The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

CORRECTED-German vaccine regulator expects unrestricted EU approval of AstraZeneca's shot

Fri, 29th Jan 2021 09:43

(Corrects final paragraph to say .. 18 to 64 ..not.. 18 and 64)

BERLIN, Jan 29 (Reuters) - The head of Germany's vaccine
regulator expects that the European Union will approve
AstraZeneca's COVID-19 vaccine without any age
restrictions, he told a news conference on Friday.

The bloc's drugs regulator, the European Medicines Agency
(EMA), is due to issue a recommendation on AstraZeneca's
vaccine, co-developed by Oxford University, later on Friday.

Klaus Cichutek, president of the Paul Ehrlich Institute,
said European regulators were in a position to approve the
vaccine without restrictions with the warning that the available
data for older age groups was weaker.

Health Minister Jens Spahn had previously said he does not
expect an unrestricted approval of the shot.

On Thursday, Germany's expert vaccine committee said
AstraZeneca's vaccine should only be given to people aged 18 to
64.
(Reporting by Kirsti Knolle and Zuzana Szymanska; writing by
Caroline Copley; editing by Thomas Seythal and Hugh Lawson)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.